PROK
ProKidney Corp.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$528.60M
P/E Ratio
—
EPS
$-0.53
Beta
1.75
52W High
$5.95
52W Low
$0.54
50-Day MA
$1.88
200-Day MA
$2.30
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About ProKidney Corp.
ProKidney Corporation. The company is headquartered in Winston-Salem, North Carolina.
Fundamentals
| Revenue (TTM) | 889,000 |
| Gross Profit (TTM) | 889,000 |
| EBITDA | $-161.92M |
| Operating Margin | -19882.00% |
| Return on Equity | -49.40% |
| Return on Assets | -30.10% |
| Revenue/Share (TTM) | $0.01 |
| Book Value | $-7.21 |
| Price-to-Book | 97.15 |
| Price-to-Sales (TTM) | 594.61 |
| EV/Revenue | 154.01 |
| EV/EBITDA | 2.13 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -1.70% |
| Shares Outstanding | $205.20M |
| Float | $135.44M |
| % Insiders | 47.64% |
| % Institutions | 24.20% |
Historical Volatility
HV 10-Day
64.58%
HV 20-Day
54.40%
HV 30-Day
61.21%
HV 60-Day
70.95%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($6.25 target)
4
Buy2
Hold1
Strong SellMore HEALTHCARE Stocks
Data last updated: 5/25/2026